Sign In
Buy VRCA
$5.22
-0.0400 (-0.760%)
At Close: Jul 31, 2026
Verrica Pharmaceuticals Announces Participation in the H.C. Wainwright 25th Annual Global Investment Conference
08:00am, Thursday, 31'st Aug 2023
WEST CHESTER, Pa., Aug. 31, 2023 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica” or “the Company”) (Nasdaq: VRCA), a dermatology therapeutics company developing medications for ski
Why Shares of Verrica Pharmaceuticals Are Plummeting on Monday
03:16pm, Monday, 24'th Jul 2023
Verrica focuses on dermatology therapeutics. The company just received approval for its first marketed product.
WEST CHESTER, Pa., July 24, 2023 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica” or “the Company”) (Nasdaq: VRCA), a dermatology therapeutics company developing medications for ski
US FDA approves Verrica's skin disease treatment
04:35pm, Friday, 21'st Jul 2023
The U.S. Food and Drug Administration has approved Verrica Pharmaceuticals Inc's treatment of a viral skin disease in adults and children aged 2 years and above, the company said on Friday.
Verrica Pharmaceuticals Announces Presentation at the RBC Capital Markets Global Healthcare Conference
07:30am, Wednesday, 10'th May 2023
WEST CHESTER, Pa., May 10, 2023 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica” or “the Company”) (Nasdaq: VRCA), a dermatology therapeutics company developing medications for skin
7 Biotech Stocks With Huge Return Potential for Long-Term Investors
08:01pm, Wednesday, 26'th Apr 2023
Standing among the most compelling opportunities, biotech stocks to buy and hold also present high risks. Unlike other sectors, companies can't just introduce health-related products directly to the m
Verrica Pharmaceuticals Announces Participation in the H.C. Wainwright 24th Annual Global Investment Conference
04:30pm, Wednesday, 31'st Aug 2022
WEST CHESTER, Pa., Aug. 31, 2022 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica”) (Nasdaq: VRCA), a dermatology therapeutics company developing medications for skin diseases requiring
Hot Penny Stocks to Buy Now? 3 to Watch in Early July
05:23pm, Wednesday, 06'th Jul 2022
Check these penny stocks out for your watchlist The post Hot Penny Stocks to Buy Now? 3 to Watch in Early July appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Here's Why Verrica Pharmaceuticals Inc. (VRCA) is Poised for a Turnaround After Losing 70.4% in 4 Weeks
11:18am, Wednesday, 01'st Jun 2022
Verrica Pharmaceuticals Inc. (VRCA) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street a
Verrica (VRCA) Down 64% as Molluscum Drug Gets CRL From FDA
05:18pm, Thursday, 26'th May 2022
Verrica Pharmaceuticals' (VRCA) new drug application for VP-102 to treat molluscum contagiosum faces rejection from the FDA for a second time.
6 Stocks Halted In Wednesday's Session: Here's Why
05:31pm, Wednesday, 25'th May 2022
A circuit breaker is an automatic, temporary trading halt on certain securities when the underlying stock is experiencing times of high volatility. It is a measure put in place to help restore and bri
RBC Capital Slashes Verrica's Price Target After Third Rejection - What's Next?
03:23pm, Wednesday, 25'th May 2022
Verrica Pharmaceuticals Inc (NASDAQ: VRCA) was slapped with a third FDA rejection for YCANTH (VP-102) as general contract manufacturing organization challenges continue to plague the approval. RBC
Why Verrica Pharma Shares Are Plunging Today
06:56am, Wednesday, 25'th May 2022
The FDA has issued a Complete Response Letter (CRL) regarding Verrica Pharmaceuticals Inc's (NASDAQ: VRCA) marketing application for VP-102 for molluscum contagiosum. The only deficiency listed in
After Plunging 28.5% in 4 Weeks, Here's Why the Trend Might Reverse for Verrica Pharmaceuticals Inc. (VRCA)
11:17am, Monday, 16'th May 2022
The heavy selling pressure might have exhausted for Verrica Pharmaceuticals Inc. (VRCA) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wa
Here's Why Verrica Pharmaceuticals Inc. (VRCA) is Poised for a Turnaround After Losing 31.6% in 4 Weeks
11:17am, Friday, 13'th May 2022
The heavy selling pressure might have exhausted for Verrica Pharmaceuticals Inc. (VRCA) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wa
